Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2024

Bristol Myers Squibb - Evolving Patient-Centered Therapies for Metastatic NSCLC

Next-Generation Tyrosine Kinase Inhibitors: The Evolving Treatment Landscape of Cancers With ROS1 or NTRK Fusions

Date

14 Sep 2024

Session

Bristol Myers Squibb - Evolving Patient-Centered Therapies for Metastatic NSCLC

Topics

Patient Education and Advocacy;  Targeted Therapy;  Immunotherapy

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Alexander Drilon

Authors

A.E. Drilon

Author affiliations

  • Medicine Department, Memorial Sloan Kettering Evelyn H. Lauder Breast Center, 10065 - New York/US

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Welcome and Introduction

Presenter: Jarushka Naidoo

Session: Bristol Myers Squibb - Evolving Patient-Centered Therapies for Metastatic NSCLC

Resources:

Webcast

Closing Remarks

Presenter: Jarushka Naidoo

Session: Bristol Myers Squibb - Evolving Patient-Centered Therapies for Metastatic NSCLC

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.